## Type I vs. Type IV Hypersensitivity: Rapid Onset Penicillin Reaction ### Clinical Presentation Analysis **Key Point:** The **immediate onset (15 minutes)** and **mast cell/basophil-mediated symptoms** (urticaria, angioedema, bronchospasm) are pathognomonic for Type I hypersensitivity, not Type IV. ### Comparative Table | Feature | Type I (IgE-mediated) | Type IV (Cell-mediated) | | --- | --- | --- | | **Onset** | Minutes to 1 hour | 24–72 hours (delayed) | | **Immune mediator** | IgE antibodies | T lymphocytes (Th1, Tc) | | **Effector cells** | Mast cells, basophils | Macrophages, T cells | | **Preformed mediators** | Histamine, tryptase, heparin | None (cytokine-dependent) | | **Symptoms** | Urticaria, angioedema, bronchospasm, anaphylaxis | Contact dermatitis, tuberculin skin test, drug-induced delayed rash | | **Mechanism** | IgE cross-linking → degranulation | Antigen presentation → T cell activation → cytokine release | ### Why Mast Cell Involvement Discriminates **High-Yield:** Type I reactions depend on **pre-sensitization with IgE antibodies** that bind to high-affinity receptors on mast cells and basophils. Upon re-exposure, cross-linking of IgE triggers **immediate degranulation** and release of **preformed mediators** (histamine, tryptase). This is the only mechanism that can produce symptoms within minutes. Type IV reactions require **de novo T cell activation and cytokine synthesis**, which takes 24–72 hours. ### Clinical Pearl **Clinical Pearl:** If a patient has **immediate symptoms** (within 1 hour) after drug exposure, think **Type I + mast cells**. If symptoms appear **after 24+ hours**, think **Type IV + T cells**. ### Mnemonic **Mnemonic:** **IMMEDIATE = IgE** (Type I); **DELAYED = T cell** (Type IV). [cite:Robbins 10e Ch 6]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.